The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Recombinant Human Erythropoietin (rhEPO)-Global Market Insights and Sales Trends 2024

Recombinant Human Erythropoietin (rhEPO)-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1836746

No of Pages : 95

Ask Your Query

Synopsis

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The global Recombinant Human Erythropoietin (rhEPO) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant Human Erythropoietin (rhEPO) in various end use industries. The expanding demands from the Hospitals and Retail Pharmacies, are propelling Recombinant Human Erythropoietin (rhEPO) market. ESRD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cancer segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Recombinant Human Erythropoietin (rhEPO) market, driven by demand from China, the second largest economy with some signs of stabilising, the Recombinant Human Erythropoietin (rhEPO) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant Human Erythropoietin (rhEPO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Recombinant Human Erythropoietin (rhEPO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Recombinant Human Erythropoietin (rhEPO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant Human Erythropoietin (rhEPO) sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Recombinant Human Erythropoietin (rhEPO) covered in this report include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc.

The global Recombinant Human Erythropoietin (rhEPO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • 3SBio
  • Shanghai Chemo
  • Chengdu Diao
  • NCPC Genetech
  • Kyowa Hakko Kirin
  • Shandong Kexing
  • Ahua Pharmaceutical
  • Biosidus
  • Dragon Pharma

Global Recombinant Human Erythropoietin (rhEPO) market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Recombinant Human Erythropoietin (rhEPO) market, Segment by Type:

  • ESRD
  • Cancer
  • HIV
  • Wounds and Neural Disease

Global Recombinant Human Erythropoietin (rhEPO) market, by Application

  • Hospitals
  • Retail Pharmacies

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Recombinant Human Erythropoietin (rhEPO) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Recombinant Human Erythropoietin (rhEPO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Recombinant Human Erythropoietin (rhEPO) Market Overview
1.1 Recombinant Human Erythropoietin (rhEPO) Product Overview
1.2 Recombinant Human Erythropoietin (rhEPO) Market Segment by Type
1.2.1 ESRD
1.2.2 Cancer
1.2.3 HIV
1.2.4 Wounds and Neural Disease
1.3 Global Recombinant Human Erythropoietin (rhEPO) Market Size by Type
1.3.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Overview by Type (2018-2029)
1.3.2 Global Recombinant Human Erythropoietin (rhEPO) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Type (2018-2023)
2 Global Recombinant Human Erythropoietin (rhEPO) Market Competition by Company
2.1 Global Top Players by Recombinant Human Erythropoietin (rhEPO) Sales (2018-2023)
2.2 Global Top Players by Recombinant Human Erythropoietin (rhEPO) Revenue (2018-2023)
2.3 Global Top Players by Recombinant Human Erythropoietin (rhEPO) Price (2018-2023)
2.4 Global Top Manufacturers Recombinant Human Erythropoietin (rhEPO) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Human Erythropoietin (rhEPO) Market Competitive Situation and Trends
2.5.1 Recombinant Human Erythropoietin (rhEPO) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Erythropoietin (rhEPO) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Erythropoietin (rhEPO) as of 2022)
2.7 Date of Key Manufacturers Enter into Recombinant Human Erythropoietin (rhEPO) Market
2.8 Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Human Erythropoietin (rhEPO) Status and Outlook by Region
3.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Region
3.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Region (2018-2023)
3.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales in Value by Region (2018-2023)
3.2.3 Global Recombinant Human Erythropoietin (rhEPO) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Region
3.3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Region (2024-2029)
3.3.2 Global Recombinant Human Erythropoietin (rhEPO) Sales in Value by Region (2024-2029)
3.3.3 Global Recombinant Human Erythropoietin (rhEPO) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Recombinant Human Erythropoietin (rhEPO) by Application
4.1 Recombinant Human Erythropoietin (rhEPO) Market Segment by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacies
4.2 Global Recombinant Human Erythropoietin (rhEPO) Market Size by Application
4.2.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Overview by Application (2018-2029)
4.2.2 Global Recombinant Human Erythropoietin (rhEPO) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales Breakdown by Application (2018-2023)
5 North America Recombinant Human Erythropoietin (rhEPO) by Country
5.1 North America Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Country
5.1.1 North America Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2018-2023)
5.1.3 North America Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2018-2023)
5.2 North America Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Country
5.2.1 North America Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2024-2029)
5.2.2 North America Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2024-2029)
6 Europe Recombinant Human Erythropoietin (rhEPO) by Country
6.1 Europe Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Country
6.1.1 Europe Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2018-2023)
6.1.3 Europe Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2018-2023)
6.2 Europe Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Country
6.2.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2024-2029)
6.2.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2024-2029)
7 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) by Region
7.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales in Value by Region (2024-2029)
8 Latin America Recombinant Human Erythropoietin (rhEPO) by Country
8.1 Latin America Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Country
8.1.1 Latin America Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2018-2023)
8.2 Latin America Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Country
8.2.1 Latin America Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2024-2029)
9 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) by Country
9.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 3SBio
10.1.1 3SBio Company Information
10.1.2 3SBio Introduction and Business Overview
10.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Products Offered
10.1.5 3SBio Recent Development
10.2 Shanghai Chemo
10.2.1 Shanghai Chemo Company Information
10.2.2 Shanghai Chemo Introduction and Business Overview
10.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Products Offered
10.2.5 Shanghai Chemo Recent Development
10.3 Chengdu Diao
10.3.1 Chengdu Diao Company Information
10.3.2 Chengdu Diao Introduction and Business Overview
10.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Products Offered
10.3.5 Chengdu Diao Recent Development
10.4 NCPC Genetech
10.4.1 NCPC Genetech Company Information
10.4.2 NCPC Genetech Introduction and Business Overview
10.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Products Offered
10.4.5 NCPC Genetech Recent Development
10.5 Kyowa Hakko Kirin
10.5.1 Kyowa Hakko Kirin Company Information
10.5.2 Kyowa Hakko Kirin Introduction and Business Overview
10.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Products Offered
10.5.5 Kyowa Hakko Kirin Recent Development
10.6 Shandong Kexing
10.6.1 Shandong Kexing Company Information
10.6.2 Shandong Kexing Introduction and Business Overview
10.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Products Offered
10.6.5 Shandong Kexing Recent Development
10.7 Ahua Pharmaceutical
10.7.1 Ahua Pharmaceutical Company Information
10.7.2 Ahua Pharmaceutical Introduction and Business Overview
10.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Products Offered
10.7.5 Ahua Pharmaceutical Recent Development
10.8 Biosidus
10.8.1 Biosidus Company Information
10.8.2 Biosidus Introduction and Business Overview
10.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Products Offered
10.8.5 Biosidus Recent Development
10.9 Dragon Pharma
10.9.1 Dragon Pharma Company Information
10.9.2 Dragon Pharma Introduction and Business Overview
10.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Products Offered
10.9.5 Dragon Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Human Erythropoietin (rhEPO) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Human Erythropoietin (rhEPO) Industrial Chain Analysis
11.4 Recombinant Human Erythropoietin (rhEPO) Market Dynamics
11.4.1 Recombinant Human Erythropoietin (rhEPO) Industry Trends
11.4.2 Recombinant Human Erythropoietin (rhEPO) Market Drivers
11.4.3 Recombinant Human Erythropoietin (rhEPO) Market Challenges
11.4.4 Recombinant Human Erythropoietin (rhEPO) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Human Erythropoietin (rhEPO) Distributors
12.3 Recombinant Human Erythropoietin (rhEPO) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock